Singapore markets open in 5 hours 22 minutes

BioXcel Therapeutics, Inc. (BTAI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1200-0.0500 (-4.27%)
As of 03:38PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-153,048
-179,053
-165,757
-106,931
-82,169
-
Depreciation & amortisation
316
318
327
297
188
-
Stock-based compensation
17,170
18,614
17,337
19,455
14,611
-
Change in working capital
11,834
2,018
10,403
4,980
1,020
-
Accounts receivable
-95
177
-248
0
-
-
Inventory
-487
-6
-1,985
0
-
-
Accounts payable
6,261
-3,219
13,030
4,850
3,197
-
Other working capital
-120,379
-155,026
-135,480
-82,598
-66,666
-
Other non-cash items
4,066
3,533
1,938
-
-
-
Net cash provided by operating activities
-120,359
-155,006
-135,341
-82,153
-66,350
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-20
-139
-445
-316
-
Net cash used for investing activities
-20
-20
-139
-445
-316
-
Cash flows from financing activities
Common stock issued
29,118
27,032
0
100,993
255,785
-
Common stock repurchased
-
-
-
0
-9,024
0
Other financing activities
108
-1,018
-2,646
-
-
179
Net cash used provided by (used for) financing activities
28,999
26,522
96,237
102,447
247,359
-
Net change in cash
-91,380
-128,504
-39,243
19,849
180,693
-
Cash at beginning of period
165,521
193,725
232,968
213,119
32,426
-
Cash at end of period
74,141
65,221
193,725
232,968
213,119
-
Free cash flow
Operating cash flow
-120,359
-155,006
-135,341
-82,153
-66,350
-
Capital expenditure
-
-20
-139
-445
-316
-
Free cash flow
-120,379
-155,026
-135,480
-82,598
-66,666
-